Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery
Clinical trial NCT00539617 · TERMINATED
Trial details
- NCT number
- NCT00539617
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-05
- Primary completion
- 2011-05-12
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.